News & Updates

Happy day for Sanofi new drug Toujeo®

Sanofi

 

Sanofi , France based company got FDA approval of its new drug Toujeo®.  Toujeo is once daily insulin based on widely used insulin glargine.

February 27, 2015 , Sanofi announces a positive opinion from European Medicines Agency (EMA) recommending  approval of Toujeo injection for treatment of type 1 and type 2 diabetic patients.

Toujeo showed higher stability and long control of glycemic conditions than Lantus.

More about story found HERE.

 

948 total views, 1 views today

Leave a Comment